Development of IL-22-producing NK lineage cells from umbilical cord blood hematopoietic stem cells in the absence of secondary lymphoid tissue

Blood

Volumn 117, Issue 15, 2011, Pages 4052-4055

  Tang, Qin ^a   Ahn, Yong Oon ^a   Southern, Peter ^b   Blazar, Bruce R ^a   Miller, Jeffery S ^a   Verneris, Michael R ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD161 ANTIGEN; CD56 ANTIGEN; CD94 ANTIGEN; CHEMOKINE RECEPTOR CCR6; GAMMA INTERFERON; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 1BETA; INTERLEUKIN 22; INTERLEUKIN 23; NATURAL CYTOTOXICITY TRIGGERING RECEPTOR 2; STEM CELL FACTOR RECEPTOR;

ANIMAL CELL; ARTICLE; CYTOKINE PRODUCTION; EMBRYO; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOSTIMULATION; LYMPHOID CELL LINE; LYMPHOID TISSUE; MESENCHYMAL STEM CELL; NATURAL KILLER CELL; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; STEM CELL; UMBILICAL CORD BLOOD;

EID: 79954609836     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2010-09-303081     Document Type: Article

References (17)

1. Crellin NK, Trifari S, Kaplan CD, Cupedo T, Spits H. Human NKp44+IL-22+ cells and LTi-like cells constitute a stable RORC+ lineage distinct from conventional natural killer cells. J Exp Med. 2010;207(2):281-290.
2. Cupedo T, Crellin NK, Papazian N, et al. Human fetal lymphoid tissue-inducer cells are interleukin 17-producing precursors to RORC+ CD127 + natural killer-like cells. Nat Immunol. 2009;10(1):66-74.
3. Hughes T, Becknell B, McClory S, et al. Stage 3 immature human natural killer cells found in secondary lymphoid tissue constitutively and selectively express the TH 17 cytokine interleukin-22. Blood. 2009;113(17):4008-4010.
4. Cella M, Fuchs A, Vermi W, et al. A human natural killer cell subset provides an innate source of IL-22 for mucosal immunity. Nature. 2009;457(7230):722-725.
5. Freud AG, Caligiuri MA. Human natural killer cell development. Immunol Rev. 2006;214:56-72. (Pubitemid 44707902)
6. Grzywacz B, Kataria N, Sikora M, et al. Coordinated acquisition of inhibitory and activating receptors and functional properties by developing human natural killer cells. Blood. 2006;108(12):3824-3833. (Pubitemid 44864565)
7. Bachanova V, McCullar V, Lenvik T, et al. Activated notch supports development of cytokine producing NK cells which are hyporesponsive and fail to acquire NK cell effector functions. Biol Blood Marrow Transplant. 2009;15(2):183-194.
8. Miller JS, Alley KA, McGlave P. Differentiation of natural killer (NK) cells from human primitive marrow progenitors in a stroma-based long-term culture system: identification of a CD34+7+ NK progenitor. Blood. 1994;83(9):2594-2601. (Pubitemid 24135852)
9. Miller JS, McCullar V, Punzel M, Lemischka IR, Moore KA. Single adult human CD34 (+)/Lin-/CD38 (-) progenitors give rise to natural killer cells, B-lineage cells, dendritic cells, and myeloid cells. Blood. 1999;93(1):96-106. (Pubitemid 29019393)
10. McCullar V, Oostendorp R, Panoskaltsis-Mortari A, et al. Mouse fetal and embryonic liver cells differentiate human umbilical cord blood progenitors into CD56-negative natural killer cell precursors in the absence of interleukin-15. Exp Hematol. 2008;36(5):598-608.
11. Freud AG, Becknell B, Roychowdhury S, et al. A human CD34 (+) subset resides in lymph nodes and differentiates into CD56bright natural killer cells. Immunity. 2005;22(3):295-304. (Pubitemid 40387472)
12. Maher DM, Zhang ZQ, Schacker TW, Southern PJ. Ex vivo modeling of oral HIV transmission in human palatine tonsil. J Histochem Cytochem. 2005;53(5):631-642. (Pubitemid 40593976)
13. Hughes T, Becknell B, Freud AG, et al. Interleukin-1beta selectively expands and sustains interleukin-22 + immature human natural killer cells in secondary lymphoid tissue. Immunity. 2010;32(6):803-814.
14. Trifari S, Spits H. IL-22-producing CD4 (+) T cells: middle-men between the immune system and its environment. Eur J Immunol. 2010;40(9):2369-2371.
15. Horny HP, Horst HA, Ehninger G, Kaiserling E. Lymph node morphology after allogeneic bone marrow transplantation for chronic myeloid leukemia: a histological and immunohistological study focusing on the phenotype of the recovering lymphoid cells. Blut. 1988;57(1):31-40.
16. Kelly RM, Goren EM, Taylor PA, et al. Short-term inhibition of p53 combined with keratinocyte growth factor improves thymic epithelial cell recovery and enhances T-cell reconstitution after murine bone marrow transplantation. Blood. 2010;115(5):1088-1097.
17. Reddy P, Ferrara JL. Immunobiology of acute graft-versus-host disease. Blood Rev. 2003;17(4):187-194. (Pubitemid 37356389)